enGene Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for enGene Therapeutics stock have an average target of 21.08, with a low estimate of 10 and a high estimate of 30. The average target predicts an increase of 202.87% from the current stock price of 6.96.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$10	$21.08	$21.5	$30
Change	+43.68%	+202.87%	+208.91%	+331.03%

Analyst Ratings

The average analyst rating for enGene Therapeutics stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	2	2	2
Buy	5	5	5	5	3	3
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Karen Sterling WBB Securities	WBB Securities	Strong Buy Initiates $22	Strong Buy	Initiates	$22	+208.91%	Apr 13, 2026
Leland Gershell Oppenheimer	Oppenheimer	Buy Maintains $33 → $30	Buy	Maintains	$33 → $30	+331.03%	Mar 11, 2026
Andres Y. Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $25	Strong Buy	Reiterates	$25	+259.20%	Mar 9, 2026
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Maintains $18 → $19	Buy	Maintains	$18 → $19	+172.99%	Nov 12, 2025
Leland Gershell Oppenheimer	Oppenheimer	Buy Reiterates $30 → $33	Buy	Reiterates	$30 → $33	+374.14%	Nov 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

24.78M

EPS This Year

-2.06

from -2.29

EPS Next Year

-2.00

from -2.06

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Oct 31, 2021	Oct 31, 2022	Oct 31, 2023	Oct 31, 2024	Oct 31, 2025	Oct 31, 2026	Oct 31, 2027
Revenue	-	-	-	-	-	-	24.78M
Revenue Growth	-	-	-	-	-	-	-
EPS	-6.25	-44.30	-151.22	-1.46	-2.29	-2.06	-2.00
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	103.0M
Avg	n/a	24.8M
Low	n/a	6.2M

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.77	-1.17
Avg	-2.06	-2.00
Low	-2.43	-2.53

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.